These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17163146)

  • 1. [Yersinia pseudotuberculosis toxins].
    Timchenko NF
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):83-9. PubMed ID: 17163146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a superantigen produced by Yersinia pseudotuberculosis.
    Abe J; Takeda T
    Prep Biochem Biotechnol; 1997; 27(2-3):173-208. PubMed ID: 9292925
    [No Abstract]   [Full Text] [Related]  

  • 3. Superantigen YPMa exacerbates the virulence of Yersinia pseudotuberculosis in mice.
    Carnoy C; Mullet C; Müller-Alouf H; Leteurtre E; Simonet M
    Infect Immun; 2000 May; 68(5):2553-9. PubMed ID: 10768943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in the functional domains of the rho-modifying toxins of Yersinia pseudotuberculosis.
    Timchenko N; Adgamov R; Ermolaeva S
    Adv Exp Med Biol; 2012; 954():261-6. PubMed ID: 22782772
    [No Abstract]   [Full Text] [Related]  

  • 5. The complete genome sequence of Yersinia pseudotuberculosis IP31758, the causative agent of Far East scarlet-like fever.
    Eppinger M; Rosovitz MJ; Fricke WF; Rasko DA; Kokorina G; Fayolle C; Lindler LE; Carniel E; Ravel J
    PLoS Genet; 2007 Aug; 3(8):e142. PubMed ID: 17784789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence.
    Grabenstein JP; Marceau M; Pujol C; Simonet M; Bliska JB
    Infect Immun; 2004 Sep; 72(9):4973-84. PubMed ID: 15321989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pathogenicity factors of Yersinia pseudotuberculosis and the pathogenetic aspects of pseudotuberculosis].
    Timchenko NF
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):25-9. PubMed ID: 9432840
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
    Viboud GI; Mejía E; Bliska JB
    Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages.
    Monnazzi LG; Carlos IZ; de Medeiros BM
    Immunol Lett; 2004 Jun; 94(1-2):91-8. PubMed ID: 15234540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.
    Logsdon LK; Mecsas J
    Infect Immun; 2006 Mar; 74(3):1516-27. PubMed ID: 16495522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the role of invasin during Yersinia pseudotuberculosis infection of mice.
    Marra A; Isberg RR
    Ann N Y Acad Sci; 1996 Oct; 797():290-2. PubMed ID: 8993384
    [No Abstract]   [Full Text] [Related]  

  • 12. [A comparative study of the role of the yadA, invA, and psaA genes in the pathogenicity of Yersinia pseudotuberculosis].
    Karataev GI; Markov AR; Siniashina LN; Miller GG; Klitsunova NV; Titova IV; Semin EG; Goncharova NI; Pokrovskaia MS; Amelina IP; Amoako K; Smirnov GB
    Mol Gen Mikrobiol Virusol; 2008; (4):10-8. PubMed ID: 19172873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel superantigenic exotoxin from Yersinia psuedotuberculosis and its position in the classification of the entire bacterial toxins.
    Uchiyama T
    Contrib Microbiol Immunol; 1995; 13():191-4. PubMed ID: 8833831
    [No Abstract]   [Full Text] [Related]  

  • 14. [Yersinia pseudotuberculosis infection].
    Takeda N
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):496-9. PubMed ID: 10088455
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of Yersinia Yop-effector delivery by translocated YopE.
    Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
    Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence.
    Black DS; Bliska JB
    Mol Microbiol; 2000 Aug; 37(3):515-27. PubMed ID: 10931345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.
    Fisher ML; Castillo C; Mecsas J
    Infect Immun; 2007 Jan; 75(1):429-42. PubMed ID: 17074849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute oral toxicity of Yersinia pseudotuberculosis to fleas: implications for the evolution of vector-borne transmission of plague.
    Erickson DL; Waterfield NR; Vadyvaloo V; Long D; Fischer ER; Ffrench-Constant R; Hinnebusch BJ
    Cell Microbiol; 2007 Nov; 9(11):2658-66. PubMed ID: 17587333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GAP activity of Yersinia YopE.
    Aili M; Hallberg B; Wolf-Watz H; Rosqvist R
    Methods Enzymol; 2002; 358():359-70. PubMed ID: 12474400
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis.
    Bozue J; Mou S; Moody KL; Cote CK; Trevino S; Fritz D; Worsham P
    Microb Pathog; 2011 Jun; 50(6):314-21. PubMed ID: 21320584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.